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Abstract 
INTRODUCTION:  Withholding (WHLST) and withdrawing life-sustaining treatments (WDLST) occurs 
in most intensive care units (ICUs) around the world to varying degrees.  
METHODS: Speakers from invited faculty of the World Federation of Societies of Intensive and 
Critical Care Medicine Congress in 2013 with an interest in ethics were approached to participate in 
an Ethics Round Table. Participants were asked if they agreed with the statement "There is NO moral 
difference between withholding and withdrawing a mechanical ventilator." Differences between 
WHLST and WDLST were discussed. Official statements relating to WHLST and WDLST from 
Intensive Care Societies, professional bodies and government statements were sourced, documented 
and compared.   
RESULTS: Sixteen respondents stated there was no moral difference between withholding or 
withdrawing a mechanical ventilator, 2 were neutral and 4 stated there was a difference. Most ethicists 
and medical organizations state there is no moral difference between WHLST and WDLST. A review 
of guidelines noted that all but one of 29 considered WHLST and WDLST as ethically or legally 
equivalent. 
CONCLUSIONS: The vast majority of respondents, practicing intensivists, stated there is no 
difference between WHLST and WDLST, supporting the majority of ethicists and professional 
organizations. A minority of physicians still do not accept their equivalency.  
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I. Introduction 
       Forty years ago, patients typically died in intensive care units (ICUs) after failed cardiopulmonary 
resuscitation (CPR). Over the ensuing years, foregoing of life-sustaining treatments has become a 
more common way for ICU patients to die. Studies around the world have demonstrated that forgoing 
of life-sustaining treatments occurs in 1.5% to 22% of patients admitted to ICUs (1-11) and that 
forgoing of life-sustaining treatments occurs in 23-93% of patients who die (2,4,6,10-16). In these 
studies, death was preceded in 8-70% of patients by withholding of life-sustaining treatments 
(4,6,9,13,15-19) and in 3-69% of patients by withdrawing of life-sustaining therapies (4,6,8,9,13,15-
19). Among individual  ICUs  within countries and regions,  withholding life-sustaining treatments may 
range from 0 to 67% (2) whilst withdrawal of life-sustaining therapies may range from 0- 96% (2,6,8) 
Clearly there is not only a significant variation in practice among the different ICUs in different 
countries, but also in different parts of a country (2,6,8). In addition, there is evidence that limiting life-
sustaining treatments has become more frequent in recent years (13). 
         The experience in neonates and children is extensive and reveals differences in approaches in 
neonatal and pediatric critical care units as well as regional variations within and between countries. 
For instance, in North America, Northern Europe and Australia it is rare in neonatal intensive care for 
infants to die while receiving CPR, and uncommon in pediatric intensive care units (PICUs). 
Generally, 18% to 65% of PICUs practice withdrawal or withholding of life sustaining therapy or 
institute DNR orders with higher rates (30 -65%) in North America and Northern Europe, while in 
Eastern Central Europe decisions to forego life sustaining therapy are almost non-existent.(20,21). 
There are also regional differences worldwide on how decisions regarding withholding or withdrawing 
life sustaining decisions are made and to what extent families are involved. In most cases decisions 
are made after discussion among the medical team and parents may be informed of the decision and 
may or may not be asked for their permission (20-25)  In addition, difficulty in reaching consensus is 
usually resolved over time (26,27) and the approach  to the use of sedatives and neuromuscular 
blockers are subject to individual preferences (23,28,29). There are also differences in approach 
depending on race and resources in that limiting therapy is less likely if the patient is black or in units 
with no trainees (30).  
       There are a number of reasons for these considerable differences in practices in the various ICUs. 
These may include legal and regulatory issues and legal precedents within the country, the religious 
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and/or cultural beliefs and practices of both the health care professionals and the patients and their 
families, the speciality of the attending physician, and the patient profile which may include the medical 
condition itself, as well as race/ethnicity and socioeconomic factors (31-39).  
       Recognizing the different worldwide contexts and practices, during the World Federation of 
Societies of Intensive and Critical Care Medicine (WFSICCM) Congress in August and September 
2013 in Durban, South Africa an Ethics Round Table was convened as a component of the scientific 
program. Round Table participants were polled as to whether they believed there was a moral 
difference between withholding or withdrawing mechanical ventilation. This paper reports their 
opinions and attempts to delineate the issues and discuss the reasons why withdrawing therapies is 
equivalent or better than withholding them or whether withholding therapies is superior to withdrawing. 
In addition, official statements relating to withholding or withdrawing life-sustaining treatments from 
Intensive Care Societies, professional bodies and government statements were sourced, documented 
and compared.    
 To highlight the differences between withholding or withdrawing mechanical ventilation 
a clinical example where those who support equivalence of withholding and withdrawing therapy or 
reject equivalence would reach different answers is provided. An 86-year old male with diffuse non-
Hodgkin lymphoma relapsing after a third course of chemotherapy with a cerebral Aspergillus infection 
undergoes a cardiac arrest in the emergency department (ED). Not being aware of the patient’s 
advance directive, the ED doctor intubates, ventilates and transfers the patient to the ICU. When the 
intensivist on call (who supports the equivalence of withholding and withdrawing therapy) discovers 
that the patient has an advance directive stating that he would not want to be intubated, ventilated or 
undergo CPR, she extubates the patient and continues other medical and palliative care.  She 
reasons that if the ER doctor would have been aware of the advance directive, he never would have 
intubated the patient in the first place and the patient’s wishes should now be respected by 
withdrawing the endotracheal tube and ventilation. Another ICU doctor (who does not support the 
equivalence of withholding and withdrawing therapy) states that the endotracheal tube and ventilation 
should not be withdrawn even though the patient would not have been intubated and ventilated if 
there would have been knowledge of the advance directive and currently the patient is receiving 
treatment he does not desire. He reasons that despite the fact that the intubation and ventilation could 
have been withheld, once started it cannot be withdrawn. 
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II. Methods 
      Speakers from the invited faculty list of the WFSICCM Congress with an interest in ethics were 
approached to participate in the Ethics Round Table. Round Table participants were asked to identify 
their three most pressing specific worldwide ethical issues that the group should address. The majority 
responded that they were interested in end-of-life issues including withholding and withdrawing life-
sustaining treatments. Seventy questions were sent to participants regarding practice in their hospitals 
and countries. There were 20 responses with variations from different countries which seemed the 
most interesting. The summary of the responses was sent to participants.  Respondents were asked 
to identify the most interesting topics for further work and discussion at the Congress. Based on the 
responses, the five topics with the greatest differences between centers and countries were chosen. 
They included questions related to withholding and withdrawing life-sustaining treatments at the end 
of life for age, health care professional end-of-life decision making, patient/family end-of-life decision 
making, how to withdraw mechanical ventilation and differences between withholding and withdrawing 
life-sustaining treatments. Prior to the Congress meeting, potential questions for the five issues were 
distributed. At the meeting and several weeks later, 76 questions were finalized using a Likert scale 
(strongly agree, agree, neutral, disagree and strongly disagree) and the round table participants 
answered the questions. The present paper summarizes opinions of participants and elaborates on 
one of the 76 questions the differences between withholding and withdrawing a mechanical ventilator."  
 
III. Results 
       Respondents’ answers to the statement "There is NO moral difference between withholding and 
withdrawing a mechanical ventilator" are outlined in Table 1. Sixteen respondents stated there was no 
moral difference between withholding or withdrawing a mechanical ventilator, 2 were neutral and 4 
stated there was a moral difference. The Round Table participant country laws or Intensive Care 
Society statements regarding differences between withholding and withdrawing life-sustaining 
treatments are shown in Table 2. 
 
IV. Organizations and government statements on the differences between withholding and 
withdrawing life-sustaining treatments 
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       It is increasingly recognized that in certain circumstances limitations of life- sustaining therapies in 
the critically ill may be both medically and ethically appropriate and in order to achieve this limitation of 
therapy, treatment may either be withheld or withdrawn.  Withholding life-sustaining treatments is 
defined as a decision not to start or increase a life-sustaining intervention whereas withdrawing life-
saving therapies is defined as a decision to actively stop a life-sustaining intervention being given (6).  
In order to guide and direct the clinical practice of healthcare professionals regarding limitation of life- 
sustaining therapies a number of professional bodies, associations and societies have drawn up 
recommendations to assist in the understanding and processes (40,56,58-63). Most ethicists, the 
President’s Commission (64) and several medical organizations (40,56,58-63) have stated that there 
is no moral difference between withdrawing life-sustaining treatments and withholding them. A review 
of life support guidelines noted that all but one of 29 considered withholding or withdrawing life 
support as ethically or legally equivalent (65).  
       The dominant ethical opinion favors the equivalence of withholding and withdrawing therapy, 
using the Equivalence Thesis (66). The Equivalence Thesis states that if there is no moral difference 
between withholding and withdrawing treatment there are no cases where it would be permissible to 
withhold treatment but it would not be permissible to withdraw the same treatment (if it had already 
been started but all other relevant factors are equal) (66). Despite these philosophical equivalencies, 
some doctors and nurses have more difficulties withdrawing than withholding life-sustaining therapies 
(67-70) and a substantial number believe they are not equivalent (67,69,70).  
 
V. Reasons why withdrawing is equivalent to or better than withholding life-sustaining treatments 
       As noted above most professional opinions are that withholding and withdrawing life-prolonging 
therapies are ethically equivalent. In fact, several of the major religions permit both the withholding 
and the withdrawing of non-beneficial life-sustaining treatments in terminally ill patients. This includes 
Christians (Roman Catholics and Protestants), Muslims and Buddhists (71). Interestingly, the Greek 
Orthodox Church equates withholding with withdrawing therapy but prohibits both as it condemns 
medical acts that do not prolong life (71). There remains, however, a diversity of views within each of 
the religions and there may be different opinions regarding withholding and withdrawing based on the 
country of origin of the patient and family or acculturation (71).  
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       In addition to noting the lack of a difference between withholding and withdrawing life-sustaining 
treatments, it has been suggested that withdrawing them may be more ethically sound (64,72).  In the 
first instance, if withdrawal of therapy were not permitted than many ICUs would be filled with patients 
who are hopelessly ill and who are receiving ongoing treatment that is not likely to benefit them and is 
contrary to the four ethical principles (72). A common additional reason given for the soundness of 
withdrawal is that if physicians are unable to withdraw therapies, there is a danger that they will not 
provide treatment, particularly in the acute situation, fearing that, once started, they will not be able to 
discontinue it (61,64,66,72). This approach may deny a patient the chance of receiving a potentially 
beneficial treatment. As a consequence patients who could have benefited may be denied potentially 
life-prolonging treatment (66). By allowing a trial of a therapy rather than withholding it, the patient will 
be given every chance there is of possibly benefiting from the treatment. In addition, after the 
therapeutic trial, there will be less uncertainty and also a better assessment of the patient’s prognosis 
(66,72). By permitting a trial of treatment, the patient is at least given a chance and only if the 
treatment is not effective is it withdrawn. If the doctor's assessment is incorrect (which occurs not 
infrequently) (73) then by withholding, no allowance is made for an error of judgment (72). By 
permitting a trial of treatment, the patient is at least given a chance (72). Adopting this approach, the 
withdrawal of life-sustaining therapies is not considered the cause of the patient's death as although 
patients may die sooner, the actions of doctors are considered “allowing the patient to die” from the 
underlying illness (61). In addition, some national societies have explicitly stated that shortening the 
dying process using analgesics/sedatives may sometimes be appropriate even in the absence of 
discomfort (74).  
VI. Reasons why withholding is not equivalent to withdrawing life-sustaining treatments 
       Although the majority of organizations and ethicists believe there is no moral difference between 
withholding and withdrawing life-sustaining treatments, some clinicians and specifically a few in the 
Round Table do not share that view (75).  One of the suggested reasons is that withholding is passive 
and withdrawing is active. Although some experts (64) state that there is no moral difference between 
actions and omissions, the fact that patients die much more frequently and quicker after the 
withdrawal of therapy is associated with a greater sense of causing the patient’s death, responsibility 
and even guilt. In the Ethicus study (6) of deaths or limitations of life-sustaining treatments in 4248 
ICU patients, patients died more frequently within 72 hours after withdrawing treatments (93%) than 
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withholding therapies (68%) and more quickly. Some philosophers have supported this view, arguing 
that since killing is defined as an act that is the proximate cause of a death, then withdrawal of life 
support is also an act of killing, although one that may be justified (61).  
       Another reason suggested for the Non-Equivalence between withholding and withdrawing therapy 
relates to the physician's duty of care (66). Doctors take on a duty of care to patients once they start to 
treat them. Therefore, although it may sometimes be ethical to withhold therapy in a critical medical 
situation, it may not be ethical to withdraw therapy. According to Nozick’s principle of original 
acquisition of holdings once a person has started on a treatment and has a holding in accordance with 
the principle of justice in acquisition, they may be entitled to that holding (76,77).  
       A third reason for the lack of equivalence relates to differences between the means versus ends. 
Although the end may be the same for a dying critically ill patient, the means as to how a patient dies 
also has significance.  According to some religions actions that hasten a patient’s death are prohibited 
(71). According to halacha or Jewish religious law the value and sanctity of human life is infinite and 
beyond measure. Therefore, any part of life is of the same worth and an act that hastens a patient’s 
death, no matter how laudable the intentions, is equated with murder. The omission, withholding or the 
termination of an intermittently given life-sustaining treatment is permitted whereas the withdrawing or 
termination of a continuously given life-sustaining therapy is prohibited (49,50). The above 
deontological concepts are probably the reason that Jewish healthcare workers are more likely to 
withhold than to withdraw therapy (78). Although withdrawing ventilators and other life-sustaining 
treatments are the most common methods of limiting therapies, there are some countries such as Israel 
where the withdrawal of a mechanical ventilator from a terminally ill patient is illegal based on The 
Terminally ill Law (49). Finally, although not a moral argument many physicians are more concerned 
about legal liability for withdrawing than withholding treatments and patients dying shortly after the 
withdrawal (79).  
 
VII. Limitations and strengths 
The present study has strengths. A group of intensivists from around the world with divergent 
cultures, religions and professional opinions and many with a specific interest in ethics 
researched, evaluated the literature, law and professional statements, voted and discussed issues 
related to withholding and withdrawing life-sustaining therapies. The present study also has 
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limitations. Although the small number of respondents represents a diverse group of intensivists 
from around the world, they cannot be regarded as representative of their country. The review of 
guidelines, law and literature was not systematic. The study does not propose to contain data 
generalizable to the entire world since many countries, cultures or religions were not represented. 
 
VIII. Conclusion 
       Although the majority of ethicists and professional organizations have stated that there is no 
moral or legal difference between withholding and withdrawing life-sustaining treatments, some health 
care professionals still do not accept their equivalency in practice. Several authors have proposed that 
health care professionals be further educated so they can accept their equivalence (66) and others 
have made proposals for implementing equivalence (66). The majority of intensive care clinicians in 
previous surveys and at the Round Table believe that there is no moral difference between 
withholding and withdrawing life-sustaining treatments other things being equal. Some clinicians find 
treatment withdrawal more difficult, possibly because of the influence of personal religious and other 
values and some jurisdictions prohibit treatment withdrawal. It may be justifiable to prefer treatment 
withholding over treatment withdrawal if a. the patient would have preferred withholding to treatment 
withdrawal or b. legal frameworks limit or prohibit treatment withdrawal. It may be justifiable to prefer 
treatment withdrawal over treatment withholding if a. the patient would have preferred withdrawal to 
treatment withholding or b. provision of a trial of treatment would yield greater certainty about 
prognosis. 
        One way around the equivalence dilemma that has been recommended is that there should be a 
change in emphasis of the guidelines regarding end of life decisions. Some authors recommend that 
the possible ethical differences between withholding and withdrawing therapy should be avoided. 
Rather the particular situation and consequences of withholding or withdrawing treatment should be 
taken into account (80). Other authors have stated that a more useful framing for this question is 
whether either or both withholding and withdrawing life-sustaining treatments are morally and ethically 
preferable to continuing life-sustaining treatments in certain circumstances, such as when the burden 
of treatment outweighs the potential for benefit. The rephrasing of these common terms focuses on 
the important issues of assessing the potential burdens and benefits of the treatments physicians offer 
(81).  
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       Unfortunately, it is unlikely that these proposals will have any effect when the reasons for not 
accepting the equivalence of withholding and withdrawing life-sustaining therapies are religious and 
deontological. Despite the differences between physician opinions, agreement can be reached that 
treatment should be compassionate and caring meeting the needs of the patients and their families 
(75). 
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Table 1. Durban Ethics Round Table Participant Responses to the statement "There 
is NO moral difference between withholding and withdrawing a mechanical ventilator" 
 
 Country Name Institution Response 
1 Australia Jeff Lipman Royal Brisbane and 
Women's Hospital, 
Brisbane  
Agree 
2 Belgium Jean-Louis 
Vincent 
Erasme University 
Hospital, Brussels 
Agree 
3 Canada Niranjan (Tex) 
Kissoon 
BC Children's Hospital 
and Sunny Hill Health 
Centre, Vancouver BC 
Agree 
4 China Bin Du Peking Union Medical 
College Hospital 
Agree 
5 France Bertrand Guidet Hopital Saint-Antoine Agree 
6 France Elie Azoulay Hopital Saint-Louis, Paris Neutral  
7 Germany Christiane Hartog Jena University Hospital, 
Jena, 
Disagree 
8 Hong Kong Gavin Joynt Prince of Wales Hospital, 
Hong Kong 
Agree 
9 Israel Charles Sprung Hadassah Hebrew 
University Medical Center, 
Jerusalem 
Disagree 
10 Saudi Arabia Khalid Shukri International Pan-Arab 
Critical Care Society, 
Jeddah 
Neutral 
11 South Africa Eric Hodgson Inkosi Albert Luthuli 
Central Hospital, Durban 
Agree 
12 South Africa Andrew Argent Memorial Children's 
Hospital, Cape Town 
Disagree 
13 South Africa  Fathima Paruk Charlotte Maxeke 
Johannesburg Academic 
Hospital 
Agree 
14 South Africa Rudo Mathivha Chris Hani-Baragwanath Agree 
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Hospital, Johannesburg, 
15 South Africa Charles Feldman Charlotte Maxeke 
Johannesburg Academic 
Hospital and University of 
the Witwatersrand, 
Johannesburg, 
Agree 
16 South Korea Younsuck Koh Asan Medical Center, 
Seoul 
Agree 
17 The 
Netherlands 
A.B.J. Groeneveld Vrije Universiteit Medical 
Centre, De Boelelaan 
Agree 
18 USA Chris Farmer Mayo Clinic, Rochester Agree 
19 USA Mitchell Levy Rhode Island Hospital, 
Providence 
Agree 
20 USA Janice 
Zimmerman 
The Methodist Hospital, 
Houston, 
Agree 
21 USA Edgar J. Jimenez Orlando Regional Medical 
Center, Orlando 
Agree 
22 USA J. Randall Curtis University of Washington, 
Seattle 
Disagree 
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Table 2. Durban Ethics Round Table Participant Country Law or Intensive care 
Society Statement regarding differences between withholding and withdrawing life-
sustaining treatments 
 
Australia- The Australian and New Zealand Intensive Care Society and College of 
Intensive Care Medicine of Australia and New Zealand have a statement on 
withholding and withdrawing treatment (40). It states that while intensive care 
treatment may be life-saving for patients with reversible critical illness, medical 
intervention can cause considerable suffering for patients and their families with little 
or no benefit. The withholding or withdrawing of specific treatments is appropriate in 
some circumstances. Withholding treatment and withdrawing treatment are legally 
and ethically equivalent. Decisions to withhold treatment should involve the same 
principles and processes as decisions to withdraw treatment. When death follows the 
withdrawal or withholding of treatment in accordance with the principles outlined in 
this statement, the cause of death is the medical condition that 
necessitates the treatment that is withheld or withdrawn. 
 
Austria and Germany- Austrian and German national societies point out that for 
decisions to limit life support withholding or withdrawing life support is regarded as 
ethically equivalent (41,42). There are also no legal differences (43). In practice, 
however, ICU physicians and nurses often find it more difficult to withdraw than to 
withhold mechanical ventilation, possibly because of the psychological “advantage” 
to keep the airway accessible.  
 
Belgium- The Belgian Society of Intensive Care Medicine states that there is no ethical or moral difference 
between withholding and withdrawing life-sustaining therapy (44). 
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Canada- Canadian Law and ethicists make no distinction between withholding versus 
withdrawing life-sustaining treatment. Clinicians often do feel that there is a difference in 
practice. The Canadian Critical Care Society position paper on withholding and withdrawing 
life-sustaining treatments (45) states that from a traditional ethical point of view there is 
no difference between the withholding or withdrawing of life support. If life support can be 
withheld, it can also be withdrawn. Nonetheless, it is generally better to provide 
treatment, with a strategy in place for later withdrawal if it is either of no medical 
benefit or proves too burdensome, than to withhold treatment altogether because of 
unfounded fears about treatment withdrawal. When it is not clear if treatment will 
be effective, the choice should be made on the side of life, and treatment should 
be provided, if this treatment is in accord with the patient's goals. On the other 
hand, when it is clear treatment will not be effective and is not in accord with 
standard medical practice or norms, the physician is not obliged to begin, 
continue, or maintain the treatment. 
 
China- Although there is no local or national legislation governing the withdrawal of 
life-sustaining treatments , in clinical practice, withdrawal of life-sustaining treatments 
is not uncommon due to the wish of the patient or family for the patient to die at 
home or because of financial issues. The final decision for withdrawal is always 
made by the family after discussion with the physicians. 
 
France- A first law defining end of life treatment in France was issued in 2005 (47). It 
was updated in 2008. The ethics committee of the French Society of intensive care 
(SRLF) issued several recommendations. The last version was updated in 2010 (48). 
The document was produced by intensivists, nurses, psychologists and specialists in 
ethics and law. It was endorsed by the French Society of intensive care (SRLF). It 
defined the circumstances together with the practical aspects of treatment limitation. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 23 
It provided a guideline for deciding and applying EOL decisions. There were no 
formal differences between withholding and withdrawing life-sustaining treatments 
given that all preliminary steps are followed and that in any case there is no pain or 
discomfort for the patient. 
 
Israel- The Dying Patient Act- 2005 (49)- The law prohibits stopping continuous life-
sustaining treatments which is viewed as an act shortening life. It does allow 
stopping intermittent life-sustaining therapies. Terminating intermittent life-sustaining 
therapies is regarded as omitting the first or next treatment as opposed to an act of 
withdrawing a treatment. The withdrawal of a ventilator (which is considered a 
continuous treatment) is an act that shortens life and is therefore forbidden. This is 
rooted in the Jewish legal concept that not only must the end be morally justified 
(allowing a suffering terminally ill patient to die) but in addition the means to achieve 
that end must be morally correct. The law, however, allows the possibility of 
changing the ventilator from a continuous treatment to an intermittent one by 
connecting a timer to the ventilator thereby allowing the ventilator to stop 
intermittently (50). There was disagreement on these issues by the committee 
developing the law and a majority opinion believed that there is a difference between 
withholding and withdrawing a life-sustaining treatment therapy. The practical 
disagreement was minimized by accepting the concept of a timer attached to a 
ventilator (50). 
 
South Africa- The law does not expressly permit doctors to withdraw life-sustaining 
treatments or make a pronouncement on the equivalence or not of withholding and 
withdrawing therapy or recognize an advance directive (“living will”) (51). However, 
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the National Health Act, 61 of 2003, section 6(1)(d) gives a competent patient the 
right to refuse treatment and in section 7, where the patient is incompetent, a 
surrogate may do so on his behalf. Withholding life-sustaining therapy is supported 
by legal precedent.  In one case (52), the judge did not find it necessary to draw a 
distinction between withholding and withdrawing treatment but applied the same 
approach to both possibilities which was to accept that, where a person’s prospects 
of recovery and quality of life are nil, such as in a persistent vegetative state, the 
withdrawing/withholding of treatment would not invariably be wrongful, based on the 
legal convictions of society. In a more recent case it was held that the constitutional 
right of access to health care was dependent on the resources available and 
therefore also limited by a lack of resources (53).  
       In South Africa withholding therapy is a decision required regularly in State 
funded practice due to resource constraints (54). Decisions tend to be made earlier 
in State funded practice due to the presence of intensivists, occurrence of regular 
multidisciplinary ward rounds and significant resource constraints (12). In contrast, in 
the private practice settings resources are less constrained and there are very few 
intensivist led closed ICUs so intensive therapy may tend to persist longer (55).  
      Fortunately, the Health Professions Council of South Africa (HPCSA), which is 
the controlling body for Medical Practitioners’, does have an ethical guideline booklet 
to guide and direct the practice of withholding and withdrawing treatment (56). The 
guideline recognizes that “life has a natural end” and that there are life support 
techniques that may sustain life artificially for many years even in patients in whom 
there is little hope of recovery (56). It indicates that the health-care professional may 
alleviate the suffering of a terminally-ill patient by withholding treatment and does not 
appear to differentiate withdrawal from withholding of treatment (56). Furthermore, it 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 25 
does indicate that the patient’s wishes need to be considered and that when a patient 
does not have the capacity to decide for themselves that the health care provider 
must respect any valid advance refusal (56). With regard to the processes of 
treatment, it recommends that a decision regarding withdrawal or withholding of life-
sustaining treatments should be made by the senior clinician in charge of the 
patient’s care with consideration of obtaining a second opinion and that there should 
be consultations between the clinician, the healthcare team and those close to the 
patient to aim to achieve consensus on what course of action would be in the best 
interest of the patient (56).  
 
The Netherlands- The Dutch Intensive Care Society formulated end of life guidelines 
for withholding or withdrawing treatment in the critically ill in accordance with Dutch 
legislation (57). This entails that intensivists, preferably in a multidisciplinary meeting 
decide on futility on the basis of which it is permissible to abstain from or stop 
treatment. There is no difference between withholding or withdrawing life-sustaining 
treatments. This is done preferably, in agreement with the family, but they do not 
have 'the last word'. In clinical practice the aim is to obtain consensus. 
 
United States- 1. Society of Critical Care Medicine (58)- A decision to withdraw a 
treatment already initiated should not necessarily be ethically regarded as more 
problematic than a decision not to initiate a treatment.  
2. American College of Chest Physicians (59)- A legal and ethical consensus has 
developed in the United States stating that there are no differences between 
withholding and withdrawing life-sustaining treatments. The President’s Commission 
and leading ethicists have stated that no moral difference exists between withholding 
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and withdrawing life-prolonging therapies. Despite this fact, health care providers 
have traditionally had greater difficulty withdrawing than withholding life-sustaining 
treatments. . 
3. American Thoracic Society (60)- Physicians and other health care providers have 
a responsibility to respect patient autonomy by withholding or withdrawing any life-
sustaining therapy as requested by an informed and capable patient. In this regard, 
there is no ethical difference between withholding and withdrawing. Helping a patient 
forgo life support under these circumstances is regarded as distinct from participating 
in assisted suicide or active euthanasia, neither of which is supported by this 
statement. 
4. American College of Critical Care Medicine (61)- Withholding and withdrawing life 
support are equivalent. 
